2m 2m 2m 2m 2m 2m 2m
MAXCYTE (MXCT)
NASDAQ
$1.39+$0.005 (+0.36%)
Price as of Jul 14, 2026 4:44 AM EDT- $147.8MMarket Cap
- -38.39%1-Year Change
- Medical DevicesIndustry
MAXCYTE (MXCT)
$1.39+$0.005 (+0.36%)
MXCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.38 | ||
Change | +$0.05 (+3.76%) | ||
Open | $1.33 | ||
High | $1.48 | ||
Low | $1.30 | ||
Previous Close | $1.33 | ||
Volume | 2,114,024 | ||
30-Day Average Volume | 1,755,511 | ||
1-Week Change | 8.66% | ||
1-Month Change | 23.21% | ||
1-Year Change | -38.39% | ||
3-Year Change | -72.56% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 107.1M | ||
Total Assets | $194.5M | ||
Market Cap | $147.8M | ||
Enterprise Value | $133.3M | ||
Period: QTR TTM FY | |||
Revenue | $9.7M | ||
Net Income | -$4.8M | ||
Free Cash Flow | -$8.2M | ||
EBIT | -$4.8M | ||
EBITDA | -$3.7M | ||
Net Working Capital | $112.7M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -36 | ||
Enterprise Value/Revenue | 14 | ||
P/B | 1 | ||
P/E | -35 | ||
PEG | -1 | ||
Price/Free Cash Flow | -18 | ||
Price/Operating Cash Flow | -18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue